QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

GelStat Stock Price, News & Analysis (OTCMKTS:GSAC)

$0.0004
+0.00 (+33.33%)
(As of 04:30 PM ET)
Compare
Today's Range
$0.0003
▼
$0.0004
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0018
Volume
2.74 million shs
Average Volume
30.44 million shs
Market Capitalization
$247,192.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsSEC FilingsShort Interest

GSAC stock logo

About GelStat Stock (OTCMKTS:GSAC)

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

GSAC Stock Price History

GSAC Stock News Headlines

November 30, 2023 | americanbankingnews.com
GelStat Corp. (OTCMKTS:GSAC) Short Interest Down 38.6% in November
September 6, 2022 | marketwatch.com
Functional Chewing Gum Market 2022 | with COVID-19 Pandemic Analysis & Future Growth Analysis by prime Key Players and Regional Forecast 2026
December 5, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
August 26, 2022 | marketwatch.com
Functional Chewing Gum Market Is PoIsed to Reflect 5.3%% CAGR by 2027 | 111 Report Pages
August 15, 2022 | reuters.com
GSAC.PK - Gelstat Corp | Stock Price & Latest News | Reuters
June 2, 2022 | finance.yahoo.com
GelStat Announces $5 Million Public Offering Under Regulation A+
June 2, 2022 | finance.yahoo.com
GelStat Provides Corporate Update on Capital Restructuring
See More Headlines
Receive GSAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GelStat and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/05/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GSAC
CUSIP
N/A
CIK
890725
Web
www.gelstat.com
Phone
(772) 212-1368
Fax
888-512-3766
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
617,980,000
Free Float
491,294,000
Market Cap
$247,192.00
Optionable
Not Optionable
Beta
1.81
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Javier G. Acosta
    CEO & Director
  • Mr. Charles F. Tarzian (Age 66)
    Chief Marketing Advisor
  • Dr. Roger K. Cady M.D.
    Chief Medical Advisor

Key Competitors

View All Competitors














GSAC Stock Analysis - Frequently Asked Questions

How have GSAC shares performed in 2023?

GelStat's stock was trading at $0.0009 on January 1st, 2023. Since then, GSAC stock has decreased by 55.6% and is now trading at $0.0004.
View the best growth stocks for 2023 here.

Are investors shorting GelStat?

GelStat saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 76,700 shares, a decrease of 38.6% from the October 31st total of 125,000 shares. Based on an average trading volume of 62,050,700 shares, the days-to-cover ratio is presently 0.0 days.
View GelStat's Short Interest.

How do I buy shares of GelStat?

Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:GSAC) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -